Diagnostics (Aug 2021)

Pericardial NT-Pro-BNP and GDF-15 as Biomarkers of Atrial Fibrillation and Atrial Matrix Remodeling in Aortic Stenosis

  • Mariana Fragão-Marques,
  • Isaac Barroso,
  • Rui Farinha,
  • Isabel M Miranda,
  • Diana Martins,
  • Jennifer Mancio,
  • João Rocha-Neves,
  • João T Guimarães,
  • Adelino Leite-Moreira,
  • Inês Falcão-Pires

DOI
https://doi.org/10.3390/diagnostics11081422
Journal volume & issue
Vol. 11, no. 8
p. 1422

Abstract

Read online

Aims: This study aimed to evaluate the association of GDF-15 and NT-pro-BNP in two different biological matrices with AF in severe aortic stenosis patients undergoing aortic valve replacement surgery (AVR), its association with atrial matrix remodeling, as well as with 30-day postoperative outcomes. Main Methods: One hundred and twenty-six patients between 2009 and 2019 with severe aortic stenosis undergoing AVR surgery in a tertiary hospital were assessed. Key Findings: pericardial fluid GDF-15 and pericardial fluid and serum NT-pro-BNP were increased in AF patients with aortic stenosis. COL1A1 and COL3A1 gene expression increased when pericardial fluid NT-pro-BNP values were higher. TIMP4 was positively correlated with pericardial fluid GDF-15. Significance: GDF-15 and NT-pro-BNP in the pericardial fluid are biomarkers of atrial fibrillation in aortic stenosis and correlate with atrial matrix remodeling. AKI is predicted by both serum and pericardial fluid GDF-15.

Keywords